ES2145561T3 - Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas. - Google Patents

Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas.

Info

Publication number
ES2145561T3
ES2145561T3 ES97401397T ES97401397T ES2145561T3 ES 2145561 T3 ES2145561 T3 ES 2145561T3 ES 97401397 T ES97401397 T ES 97401397T ES 97401397 T ES97401397 T ES 97401397T ES 2145561 T3 ES2145561 T3 ES 2145561T3
Authority
ES
Spain
Prior art keywords
derivatives
substituted
polyalkylenpoliamides
bencil
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97401397T
Other languages
English (en)
Inventor
Jean-Baptiste Galey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2145561T3 publication Critical patent/ES2145561T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

DERIVADO(S) SUSTITUIDO(S) DE POLIALQUILENO UE CORRESPONDEN A LA SIGUIENTE FORMULA (I): EN LA QUE: N Y M = 2, 3 O 4, P = 2 O 3, X = 0, 1 O 2, R{SUB,1} Y R{SUB,4}, IDENTICOS O DIFERENTES, REPRESENTAN (I) UN RADICAL ALQUILO, LINEAL O RAMIFICADO, EN C{SUB,1} C{SUB,4}, O (II) UN RADICAL DE FORMULA: EN LA QUE: Z{SUB,1} REPRESENTA OH U OR, Z{SUB,2} Y Z{SUB,3} REPRESENTAN H, OH U OR, SIENDO R UN RADICAL ALQUILO, LINEAL O RAMIFICADO EN C{SUB,1} OS O DIFERENTES, REPRESENTAN H, UN RADICAL ALQUILO, LINEAL O RAMIFICADO, EN C{SUB,1} UN RADICAL DE LA SIGUIENTE FORMULA (B): R''{SUB,1}, R''{SUB,4} Y R''{SUB,5} REPRESENTAN H O UN RADICAL ALQUILO, LINEAL EN C{SUB,1} O RAMIFICADO EN C{SUB,1} ), SIEMPRE QUE UNO AL MENOS DE LOS RADICALES R{SUB,1}, R{SUB,2}, R{SUB,3}, R{SUB,4} O R{SUB,5} REPRESENTA UN RADICAL DE FORMULA (A), Y QUE CUANDO R{SUB,1} Y R{SUB,4} IDENTICOS, REPRESENTAN UN RADICAL DE FORMULA (A), SIENDO X, 0 O 1, Z{SUB,1} O Z{SUB,1} Y Z{SUB,2} IDENTICOS, NO PUEDEN REPRESENTAR OR, SIENDO R UN RADICAL ALQUILO EN C{SUB,1} EJOS METALICOS. UTILIZACION EN COMPOSICIONES COSMETICAS Y FARMACEUTICAS PARA PROTEGER EL ORGANISMO CONTRA EL STRESS OXIDANTE.
ES97401397T 1996-06-18 1997-06-18 Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas. Expired - Lifetime ES2145561T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607541A FR2749845B1 (fr) 1996-06-18 1996-06-18 Nouveaux derives benzyl substitue(s) de polyalkylene-polyamines et leur utilisation dans des compositions cosmetiques et pharmaceutiques

Publications (1)

Publication Number Publication Date
ES2145561T3 true ES2145561T3 (es) 2000-07-01

Family

ID=9493149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97401397T Expired - Lifetime ES2145561T3 (es) 1996-06-18 1997-06-18 Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas.

Country Status (8)

Country Link
US (1) US5910513A (es)
EP (1) EP0816324B1 (es)
JP (1) JPH10147558A (es)
AT (1) ATE189806T1 (es)
CA (1) CA2208581A1 (es)
DE (1) DE69701301T2 (es)
ES (1) ES2145561T3 (es)
FR (1) FR2749845B1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763505B1 (fr) * 1997-05-22 2000-10-06 Oreal Utilisation en cosmetique de certains polymeres polyamines comme agents anti-oxydants
FR2763851B1 (fr) * 1997-05-28 1999-07-09 Oreal Compositions comprenant un derive de dibenzoylmethane et un polymere polyamine
FR2763852B1 (fr) 1997-05-28 1999-07-09 Oreal Composition comprenant un derive de l'acide cinnamique et un polymere polyamine
US6264966B1 (en) * 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
US7754765B2 (en) * 2000-12-01 2010-07-13 Radical Vision Therapeutics Inc Copper chelators for treating ocular inflammation
US20030224028A1 (en) * 2002-05-13 2003-12-04 Societe L'oreal S.A. Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal
US7504422B2 (en) * 2003-04-02 2009-03-17 Taigen Biotechnology Co. Ltd. Polyamine compounds
EP1608352B1 (en) * 2003-04-02 2009-12-30 Taigen Biotechnology Polyamine compounds for treating chemokine receptor mediated diseases
US7501526B2 (en) * 2005-01-20 2009-03-10 Taigen Biotechnology Synthesis of polyamine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393757A (en) * 1986-12-02 1995-02-28 University Of Florida Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment
AU602186B2 (en) * 1987-02-03 1990-10-04 Merrell Dow Pharmaceuticals Inc. Novel polyamine derivatives
US5719193A (en) * 1989-05-23 1998-02-17 Merrell Pharmaceuticals, Inc. Method of potentiating cell-mediated immunity utilizing polyamine derivatives
GB9220921D0 (en) * 1992-10-05 1992-11-18 Merrell Dow Pharma Polyamine derivatives as anticytomegaloviral agents
DE69326776T2 (de) * 1992-11-13 2000-03-02 Oreal Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress

Also Published As

Publication number Publication date
FR2749845B1 (fr) 1998-08-21
CA2208581A1 (fr) 1997-12-18
JPH10147558A (ja) 1998-06-02
EP0816324A1 (fr) 1998-01-07
ATE189806T1 (de) 2000-03-15
EP0816324B1 (fr) 2000-02-16
FR2749845A1 (fr) 1997-12-19
DE69701301D1 (de) 2000-03-23
US5910513A (en) 1999-06-08
DE69701301T2 (de) 2000-09-14

Similar Documents

Publication Publication Date Title
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
DE69623764T2 (de) 1,3-propandiol-derivate als bioaktive verbindungen
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ES2145561T3 (es) Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas.
CA2138289A1 (en) N-substituted azabicycloheptane derivatives, the preparation and use thereof
FR2639225B1 (fr) Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
IL102361A (en) Benzomorphan derivatives their preparation and pharmaceutical compositions containing them
FR2737205B1 (fr) Nouveaux derives de n,n'-di(aralkyl) n,n'-di(2-azaaralkyl) alkylene diamine et leur utilisation dans des compositions pharmaceutiques et cosmetiques
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
NO954139D0 (no) Kinoksaliner, deres fremstilling og anvendelse
IL117150A (en) Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
TW252979B (es)
DE69102191D1 (de) Benzotriazolderivate enthaltende Schmiermittelzusammensetzungen.
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
GR74782B (es)
IL99369A0 (en) Pharmaceutical compositions containing substituted 2-cyclohexene derivatives
NZ240280A (en) Ergoline derivatives and pharmaceutical compositions
DK0553647T3 (da) Vandige polymerisatsammensætninger
IT8920275A0 (it) Composizione farmaceutica per uso topico oftalmico contenente bendazac o 5 oh bendazac.
MX9605026A (es) Analisis de imagen de diagnostico con complejos de metal.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 816324

Country of ref document: ES